Jade Biosciences, Inc. ( JBIO) - Key Metrics
JBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.91 | -$0.72 | -$0.72 |
| 2026Q1 | $0 | -$0.70 | -$0.42 | -$0.42 |
| 2025Q4 | $0 | -$0.45 | -$0.48 | -$0.48 |
| 2025Q3 | $0 | -$0.64 | -$0.56 | -$0.56 |
| 2025Q2 | $0 | -$1.13 | -$0.71 | -$0.71 |
JBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.31 |
| 2026Q1 | 0% | -5.02 |
| 2025Q4 | 0% | -8.57 |
| 2025Q3 | 0% | -3.37 |
| 2025Q2 | -212.34% | -2.21 |
JBIO
Price: $21.38
52 week price:
Earnings Per Share: -1.02 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion